Pharmacoepidemiology and Drug Safety

期刊简介：The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.Particular areas of interest include:design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;assessments of harm versus benefit in drug therapy;patterns of drug utilization;relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.

【译文】《药事流行病学与药物安全性》旨在为药事流行病学领域的国际交流与评估提供平台，包括数据、方法与观点。该期刊发表同行评审的原创研究报告、特邀评论以及各种客座编辑和评论文章，涵盖药事流行病学和药物安全性上市后监测的科学、医学、统计学、法律和经济方面。这些类别中的适当材料也可能被考虑作为简报发表。特别感兴趣的研究领域包括：研究特定药物、生物制品或医疗设备的益处或安全性的设计、分析、结果和解释，包括药物警戒、上市后监测、药效经济学、患者安全、分子药事流行病学或药事流行病学广泛领域内的任何其他研究；与药物、生物制品和医疗设备相关的比较有效性研究。比较有效性研究是在真实世界中比较预防、诊断、治疗和监测临床状况的替代方法的益处和危害的证据生成和综合；与药事流行病学相关的方法论贡献，无论是原创贡献、现有方法的评论还是药事流行病学方法应用的教程；药物治疗的利弊评估；药物使用模式；药事流行病学与监管指南的制定和解释之间的关系；与药物、生物制品和医疗设备相关的风险管理计划和项目的评估。